Fractyl Health, a groundbreaking healthcare company based in Boston, MA, is revolutionizing the way we understand and treat diabetes. Through their innovative approach, they are rewriting the rules of diabetes management and offering new hope to millions of people worldwide.
At the core of Fractyl Health's approach is their revolutionary therapy called Revita™. This minimally invasive procedure is designed to target the root cause of type 2 diabetes - the lining of the small intestine. By using advanced endoscopic techniques, Fractyl Health's team of experts can directly access and treat the intestinal lining, effectively resetting the body's metabolic function.
Here's how it works: during the Revita™ procedure, a catheter is inserted through the mouth and guided to the duodenum, the first part of the small intestine. Once in place, radiofrequency energy is delivered to the targeted areas, creating controlled thermal lesions. These lesions stimulate a regenerative response in the intestinal lining, leading to improved insulin sensitivity and glucose control.
The results of Fractyl Health's therapy have been nothing short of remarkable. In a clinical study published in the journal Diabetes Care, patients who underwent the Revita™ procedure experienced significant improvements in their diabetes management. After six months, their HbA1c levels, a key indicator of blood sugar control, dropped by an average of 1.3%, and their fasting plasma glucose levels decreased by an average of 18 mg/dL.
What sets Fractyl Health apart is their commitment to scientific rigor and evidence-based medicine. Their approach is backed by extensive research and clinical trials. In addition to the aforementioned study, Fractyl Health has conducted multiple trials to evaluate the safety and efficacy of their therapy. These studies have consistently demonstrated the positive impact of Revita™ on diabetes management.
Fractyl Health's groundbreaking work in diabetes treatment has not gone unnoticed. They have received recognition and support from leading healthcare organizations and investors. In fact, they have raised over $100 million in funding to further develop and expand their therapy.
By rewriting the rules of diabetes management, Fractyl Health is offering a glimmer of hope to the millions of individuals suffering from this chronic condition. Their innovative approach, supported by scientific evidence, has the potential to transform the lives of patients and redefine the future of diabetes care.
References:
Fractyl Health. (n.d.). About. Retrieved from https://www.fractyl.com/about/
Rodriguez, J., et al. (2020). A Randomized Clinical Trial of the Efficacy and Safety of REVITA DMR in the Treatment of Type 2 Diabetes. Diabetes Care, 43(3), 616-619. doi: 10.2337/dc19-1847

How to Contact Us: 
Website: https://www.fractyl.com/
Linkedin: https://www.linkedin.com/company/fractyl-health/
Twitter: https://twitter.com/fractylhealth?lang=en
Facebook: https://www.facebook.com/FractylHealth
Call us: +1 781-902-8800
Address: 17 Hartwell Ave, Lexington, MA 02421, USA